Elisabeth M. Wever

1.1k total citations
11 papers, 536 citations indexed

About

Elisabeth M. Wever is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Elisabeth M. Wever has authored 11 papers receiving a total of 536 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 7 papers in Oncology and 3 papers in Surgery. Recurrent topics in Elisabeth M. Wever's work include Prostate Cancer Diagnosis and Treatment (10 papers), Prostate Cancer Treatment and Research (9 papers) and Colorectal Cancer Screening and Detection (4 papers). Elisabeth M. Wever is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (10 papers), Prostate Cancer Treatment and Research (9 papers) and Colorectal Cancer Screening and Detection (4 papers). Elisabeth M. Wever collaborates with scholars based in Netherlands, United States and Sweden. Elisabeth M. Wever's co-authors include Eveline A.M. Heijnsdijk, Harry J. de Koning, Gerrit Draisma, Monique J. Roobol, Ruth Etzioni, Alex Tsodikov, Roman Gulati, Angela B. Mariotto, David F. Penson and Chris H. Bangma and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Cancer and The Journal of Urology.

In The Last Decade

Elisabeth M. Wever

11 papers receiving 520 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elisabeth M. Wever Netherlands 9 400 220 84 64 63 11 536
R. Gulati United States 2 454 1.1× 230 1.0× 104 1.2× 86 1.3× 43 0.7× 4 617
Ashley Maltz United States 3 324 0.8× 143 0.7× 81 1.0× 39 0.6× 32 0.5× 5 455
Chris Bangma Netherlands 12 336 0.8× 105 0.5× 122 1.5× 72 1.1× 19 0.3× 28 547
John J. Haluschak United States 7 661 1.7× 284 1.3× 119 1.4× 42 0.7× 18 0.3× 8 763
Jean-François Caubet United States 6 255 0.6× 200 0.9× 51 0.6× 44 0.7× 19 0.3× 8 473
Stephen A. Brassell United States 18 598 1.5× 147 0.7× 132 1.6× 144 2.3× 19 0.3× 28 736
Thomas H. Douglas United States 10 411 1.0× 129 0.6× 63 0.8× 69 1.1× 15 0.2× 12 503
Marniza Saad Malaysia 10 246 0.6× 158 0.7× 75 0.9× 68 1.1× 61 1.0× 51 425
Manfred Wirth United Kingdom 7 357 0.9× 115 0.5× 129 1.5× 49 0.8× 17 0.3× 7 517
Taryn Stoffs United States 6 232 0.6× 208 0.9× 72 0.9× 74 1.2× 19 0.3× 7 526

Countries citing papers authored by Elisabeth M. Wever

Since Specialization
Citations

This map shows the geographic impact of Elisabeth M. Wever's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabeth M. Wever with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabeth M. Wever more than expected).

Fields of papers citing papers by Elisabeth M. Wever

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisabeth M. Wever. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabeth M. Wever. The network helps show where Elisabeth M. Wever may publish in the future.

Co-authorship network of co-authors of Elisabeth M. Wever

This figure shows the co-authorship network connecting the top 25 collaborators of Elisabeth M. Wever. A scholar is included among the top collaborators of Elisabeth M. Wever based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabeth M. Wever. Elisabeth M. Wever is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Heijnsdijk, Eveline A.M., Tiago M. de Carvalho, Anssi Auvinen, et al.. (2014). Cost-effectiveness of Prostate Cancer Screening: A Simulation Study Based on ERSPC Data. JNCI Journal of the National Cancer Institute. 107(1). 366–366. 112 indexed citations
2.
Wever, Elisabeth M., Eveline A.M. Heijnsdijk, Gerrit Draisma, et al.. (2013). Treatment of local–regional prostate cancer detected by PSA screening: benefits and harms according to prognostic factors. British Journal of Cancer. 108(10). 1971–1977. 11 indexed citations
3.
Heijnsdijk, Eveline A.M., Elisabeth M. Wever, & Harry J. de Koning. (2012). 1213 COST-EFFECTIVENESS OF PROSTATE CANCER SCREENING BASED ON THE EUROPEAN RANDOMISED STUDY OF SCREENING FOR PROSTATE CANCER. The Journal of Urology. 187(4S). 5 indexed citations
4.
Etzioni, Ruth, Roman Gulati, Alex Tsodikov, et al.. (2012). The prostate cancer conundrum revisited. Cancer. 118(23). 5955–5963. 107 indexed citations
5.
Heijnsdijk, Eveline A.M., Elisabeth M. Wever, & Harry J. de Koning. (2012). 1450 THE TRUE BENEFIT OF PSA-SCREENING: MODELING THE IMPACT OF TRIAL SETTING AND PROTOCOL ON MORTALITY. The Journal of Urology. 187(4S). 1 indexed citations
6.
Wever, Elisabeth M., Jonas Hugosson, Eveline A.M. Heijnsdijk, et al.. (2012). To be screened or not to be screened? Modeling the consequences of PSA screening for the individual. British Journal of Cancer. 107(5). 778–784. 19 indexed citations
7.
Gulati, Roman, Alex Tsodikov, Elisabeth M. Wever, et al.. (2012). The impact of PLCO control arm contamination on perceived PSA screening efficacy. Cancer Causes & Control. 23(6). 827–835. 47 indexed citations
8.
Gulati, Roman, Elisabeth M. Wever, Alex Tsodikov, et al.. (2011). What If I Don't Treat My PSA-Detected Prostate Cancer? Answers from Three Natural History Models. Cancer Epidemiology Biomarkers & Prevention. 20(5). 740–750. 34 indexed citations
9.
Wever, Elisabeth M., Gerrit Draisma, Eveline A.M. Heijnsdijk, & Harry J. de Koning. (2011). How Does Early Detection by Screening Affect Disease Progression?. Medical Decision Making. 31(4). 550–558. 33 indexed citations
10.
Wever, Elisabeth M., Gerrit Draisma, Eveline A.M. Heijnsdijk, et al.. (2010). Prostate-Specific Antigen Screening in the United States vs in the European Randomized Study of Screening for Prostate Cancer–Rotterdam. JNCI Journal of the National Cancer Institute. 102(5). 352–355. 40 indexed citations
11.
Heijnsdijk, Eveline A.M., et al.. (2009). Overdetection, overtreatment and costs in prostate-specific antigen screening for prostate cancer. British Journal of Cancer. 101(11). 1833–1838. 127 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R. Gulati Breakdown of academic impact, for papers by Ashley Maltz Breakdown of academic impact, for papers by Chris Bangma Breakdown of academic impact, for papers by John J. Haluschak Breakdown of academic impact, for papers by Jean-François Caubet Breakdown of academic impact, for papers by Stephen A. Brassell Breakdown of academic impact, for papers by Thomas H. Douglas Breakdown of academic impact, for papers by Marniza Saad Breakdown of academic impact, for papers by Manfred Wirth Breakdown of academic impact, for papers by Taryn Stoffs
Rankless by CCL
2026